+

DE602006014126D1 - Zusammensetzungen und verfahren zur trennung von fusionsproteinen - Google Patents

Zusammensetzungen und verfahren zur trennung von fusionsproteinen

Info

Publication number
DE602006014126D1
DE602006014126D1 DE602006014126T DE602006014126T DE602006014126D1 DE 602006014126 D1 DE602006014126 D1 DE 602006014126D1 DE 602006014126 T DE602006014126 T DE 602006014126T DE 602006014126 T DE602006014126 T DE 602006014126T DE 602006014126 D1 DE602006014126 D1 DE 602006014126D1
Authority
DE
Germany
Prior art keywords
compositions
fusion proteins
separating fusion
separating
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006014126T
Other languages
English (en)
Inventor
Sujeong Kim
Jong-Mook Kim
Song Shan Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helixmith Co Ltd
Original Assignee
Viromed Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viromed Co Ltd filed Critical Viromed Co Ltd
Publication of DE602006014126D1 publication Critical patent/DE602006014126D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5412IL-6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5431IL-11
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57581Thymosin; Related peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
DE602006014126T 2005-04-20 2006-04-20 Zusammensetzungen und verfahren zur trennung von fusionsproteinen Active DE602006014126D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67287905P 2005-04-20 2005-04-20
PCT/IB2006/002378 WO2006126102A2 (en) 2005-04-20 2006-04-20 Compositions and methods for fusion protein separation

Publications (1)

Publication Number Publication Date
DE602006014126D1 true DE602006014126D1 (de) 2010-06-17

Family

ID=37452418

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006014126T Active DE602006014126D1 (de) 2005-04-20 2006-04-20 Zusammensetzungen und verfahren zur trennung von fusionsproteinen

Country Status (8)

Country Link
US (2) US7585943B2 (de)
EP (1) EP1871785B1 (de)
JP (1) JP4897792B2 (de)
KR (1) KR101312339B1 (de)
CN (1) CN101287748B (de)
AT (1) ATE466868T1 (de)
DE (1) DE602006014126D1 (de)
WO (1) WO2006126102A2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602006014126D1 (de) * 2005-04-20 2010-06-17 Viromed Co Ltd Zusammensetzungen und verfahren zur trennung von fusionsproteinen
KR100984635B1 (ko) 2005-07-15 2010-10-01 주식회사 바이오톡스텍 티모신 β4 유도체 및 이의 용도
US20080069796A1 (en) * 2006-07-31 2008-03-20 Kim Jong-Mook Low Dose Treatment with an Interleukin-11 Analog
US8206837B2 (en) * 2007-01-12 2012-06-26 Terumo Kabushiki Kaisha Interventional medical device
KR101701080B1 (ko) * 2007-06-21 2017-01-31 엑스엘-프로테인 게엠베하 증가된 생체내 및/또는 시험관내 안정성을 갖는 생물학적 활성 단백질
EP2205618B1 (de) * 2007-09-26 2016-11-09 Intrexon Corporation Synthetische 5'-utrs, expressionsvektoren und verfahren zur erhöhung der transgenexpression
KR100980457B1 (ko) 2008-06-27 2010-09-07 한국생명공학연구원 대장균에서 활성형 인간 인터루킨-6의 생산 및 정제방법
MX2011002055A (es) * 2008-08-25 2011-03-30 Viromed Co Ltd Conjugados de biopolimeros que contienen un analogo de interleucina-11.
KR101016766B1 (ko) 2009-01-15 2011-02-25 한국과학기술연구원 티오레독신이 융합된 단백질 발현용 플라스미드 및 이를 이용한 목적 단백질의 생산방법
CN102262158A (zh) * 2010-05-27 2011-11-30 戴国祯 重组融合蛋白质在快速诊断检测中的直接应用
WO2011151721A1 (en) 2010-06-04 2011-12-08 Lupin Limited Process for production of fusion proteins using truncated e. coli thioredoxin
WO2011151716A1 (en) 2010-06-04 2011-12-08 Lupin Limited Process for the purification of recombinant human il-11
CN103179982A (zh) * 2010-08-05 2013-06-26 科学与工业研究委员会 具有溶血栓和抗凝血性质的蛋白融合构建体
CN102161700A (zh) * 2011-01-19 2011-08-24 温州医学院 一种新型人白细胞介素-11
CN106279433A (zh) * 2011-03-04 2017-01-04 夏尔人类遗传治疗公司 用于多肽组成物的肽连接物及其使用方法
US8580922B2 (en) 2011-03-04 2013-11-12 Shire Human Genetic Therapies, Inc. Peptide linkers for polypeptide compositions and methods for using same
KR20140036905A (ko) * 2012-09-18 2014-03-26 삼성전자주식회사 이중특이 항체를 포함하는 단백질 복합체
WO2014084432A1 (ko) * 2012-11-30 2014-06-05 경상대학교 산학협력단 헬리코박터 파일로리 발현 벡터
US20140364368A1 (en) * 2013-06-06 2014-12-11 Massachusetts Institute Of Technology Stimulus responsive nanocomplexes and methods of use thereof
CN105473610A (zh) * 2013-08-21 2016-04-06 卡迪拉保健有限公司 用于pth的纯化方法
KR101814048B1 (ko) 2014-01-28 2018-01-02 (주)에이피테크놀로지 대량 생산이 가능하도록 개선된 경구투여용 트롬보포이에틴 및 이의 대량 생산공정
EP3227455B1 (de) 2014-12-01 2023-07-12 Pfenex Inc. Fusionspartner zur herstellung von peptiden
CN104437411A (zh) * 2014-12-15 2015-03-25 武汉大学 可逆组装和分解的Strep-tag多肽标记的生物分子衍生化基质及其应用
CN106884030A (zh) * 2015-12-16 2017-06-23 丰益(上海)生物技术研发中心有限公司 提高含纤维素结合域的融合蛋白的发酵产量的方法
JP6758889B2 (ja) * 2016-04-07 2020-09-23 シスメックス株式会社 標的タンパク質の精製方法
WO2020113403A1 (en) * 2018-12-04 2020-06-11 Beijing Percans Oncology Co. Ltd. Cytokine fusion proteins
EP3743438A4 (de) 2018-01-24 2022-02-23 Beijing Percans Oncology Co. Ltd. Cytokinfusionsproteine
KR102140531B1 (ko) * 2018-08-07 2020-08-04 (주)휴온스 Gly-Tβ4의 제조방법
CN114805598A (zh) * 2019-04-28 2022-07-29 广州市雷德生物科技有限公司 促进蛋白二聚体形成的拉链扣结构及其应用
CN110484551B (zh) * 2019-07-29 2021-04-02 因之彩生物科技(武汉)有限公司 金属硫蛋白表达载体及其应用
CA3158412A1 (en) * 2019-10-22 2021-04-29 Icahn School Of Medicine At Mount Sinai Recombinant neuraminidase and uses thereof
CN111909947B (zh) * 2020-08-04 2022-06-07 辽宁省海洋水产科学研究院 一种仿刺参β-胸腺素的制备及应用
CN112946041B (zh) * 2021-02-06 2022-07-22 自然资源部第一海洋研究所 一种基于融合蛋白传感器的重金属离子检测方法
CN115078728B (zh) * 2021-03-11 2024-10-22 盛禾(中国)生物制药有限公司 一种融合蛋白的快速分析方法
CN114644715B (zh) * 2022-03-04 2024-08-20 苏州红冠庄国药股份有限公司 一种igfbp-3和igf-1的融合蛋白及复合物制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO117329B1 (ro) * 1991-06-24 2002-01-30 Chiron Corp Emeryville Polipeptide care contin o secventa a virusului hepatitei c
US5820866A (en) 1994-03-04 1998-10-13 National Jewish Center For Immunology And Respiratory Medicine Product and process for T cell regulation
JP3828214B2 (ja) * 1996-11-08 2006-10-04 株式会社クラレ ペプチドおよびその塩
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
DE19822823A1 (de) * 1998-05-20 2000-02-10 Basf Ag Neue Peptidfragmente zur Reinigung von Proteinen
EP2280030A3 (de) * 2001-04-10 2011-06-15 Agensys, Inc. Nukleinsäuren und zugehörige Proteine für die Behandlung und den Nachweis von Krebs
ATE512216T1 (de) * 2001-04-10 2011-06-15 Agensys Inc Nukleinsäure und dieser entsprechendes, 184p1e2 genanntes, für die behandlung und den nachweis von krebs geeignetes protein
US7034134B2 (en) 2001-04-26 2006-04-25 Bristol-Myers Squibb Company Polynucleotide encoding a novel metalloprotease highly expressed in the testis, MMP-29
FR2831170B1 (fr) * 2001-10-19 2004-03-19 Inst Nat Sante Rech Med Proteines c modifiees activables directement par la thrombine
CA2484941A1 (en) 2002-07-24 2004-02-05 Intercell Ag Antigens encoded by alternative reading frame from pathogenic viruses
US20040210036A1 (en) * 2003-04-15 2004-10-21 Nanogen, Inc. Peptide substrate libraries
WO2005007090A2 (en) 2003-07-03 2005-01-27 President And Fellows Of Harvard College Inhibitors of the map kinase pathway
JP2005049164A (ja) * 2003-07-31 2005-02-24 Shimadzu Corp ペプチドの高感度測定又は定量のためのラベル化試薬及び方法
WO2005035003A2 (en) * 2003-09-22 2005-04-21 Dihedron Corporation Compositions and methods for increasing drug efficiency
CN1666995A (zh) * 2004-03-11 2005-09-14 许日山 一种经切割后能产生多种有效成分的前体蛋白
CA2576293C (en) 2004-07-12 2016-10-04 Nicola J. Mabjeesh Agents capable of downregulating an msf-a-dependent hif-1alpha and use thereof in cancer treatment
EP1786451A4 (de) * 2004-08-06 2009-07-22 Sopherion Therapeutics Inc Antiangiogene peptide und verfahren zu ihrer verwendung
DE602006014126D1 (de) 2005-04-20 2010-06-17 Viromed Co Ltd Zusammensetzungen und verfahren zur trennung von fusionsproteinen

Also Published As

Publication number Publication date
US7585943B2 (en) 2009-09-08
CN101287748A (zh) 2008-10-15
CN101287748B (zh) 2013-03-27
EP1871785A2 (de) 2008-01-02
WO2006126102A8 (en) 2008-05-15
ATE466868T1 (de) 2010-05-15
US8106158B2 (en) 2012-01-31
EP1871785A4 (de) 2009-03-18
JP2008539696A (ja) 2008-11-20
KR101312339B1 (ko) 2013-09-27
KR20080002845A (ko) 2008-01-04
US20060276625A1 (en) 2006-12-07
HK1125387A1 (en) 2009-08-07
JP4897792B2 (ja) 2012-03-14
EP1871785B1 (de) 2010-05-05
WO2006126102A2 (en) 2006-11-30
US20080171852A9 (en) 2008-07-17
US20100285526A1 (en) 2010-11-11

Similar Documents

Publication Publication Date Title
DE602006014126D1 (de) Zusammensetzungen und verfahren zur trennung von fusionsproteinen
DK1781697T3 (da) Nyt carbamyleret erythropoietinprotein samt fremstillingsmetode
PE20120170A1 (es) Variantes de union a anti-albumina de suero mejoradas
NZ597756A (en) Method for purifying recombinant adamts13 and other proteins and compositions thereof
WO2007103447A3 (en) A method for the preparation of recombinant human thrombin
ATE431834T1 (de) Prozess zur trennung von proteinen
DE60335733D1 (de) Verfahren zur solubilisierung von protein
WO2004092199A3 (en) Method for identifying modulators of g protein coupled receptor signaling
IS2786B (is) Prótín sem bindast viðtaka Nogo
DE602005009856D1 (de) Verfahren zur reinigung von fsh
DE602005026855D1 (de) Vorrichtungen und verfahren zur bestimmung von proteaseaktivität
DE502007004242D1 (de) DNS-Konstrukt und Verfahren zur fermentativen Herstellung von Fusionsproteinen
ATE525466T1 (de) Verfahren und testkit zur trennung, aufreinigung und wiedergewinnung von lang- und kurzkettigen nukleinsäuren
ATE491157T1 (de) Verfahren zum nachweis und zur entfernung von endotoxin
DE602004032345D1 (de) Reagenzien und verfahren zur bildung von disulfid-bindungen und glykosylierung von proteinen
WO2005060350A3 (en) Diastereomeric peptides useful as inhibitors of membrane protein assembly
DE602004030041D1 (de) Verfahren und zusammensetzungen zur identifikation von rna-bindenden proteinen
ATE498016T1 (de) Transposon-system zur gezielten integration
ATE408616T1 (de) Verfahren zur aufreinigung von il-18-bindendem protein
EP1942094A4 (de) Verfahren zur rückgewinnung von wolfram
ATE403480T1 (de) Verfahren und ausrüstungen zur reinigung von proteinen mit his-tag
WO2006097336A3 (en) A novel component of the wg/wnt signaling pathway
GB201200554D0 (en) Metal abstraction peptide and uses thereof
ATE499379T1 (de) Ein tag für die reinigung von peptiden
IL157309A0 (en) Method for the purification of a non-immunoglobulin protein

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载